drugset / Trial / NCT01888536

A Study to Evaluate Efficacy of 『Opast Tablet』for Neurologic Claudication in Patients With Lumbar Spinal Stenosis

NCT01888536

Phase 4 Completed 182 enrolled Yungjin Pharm. Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This trial is a comparative study of Opast tablet and Rikalin capsule 75mg and Rikalin capsule 75mg in combination with Opast tablet to evaluate improvement effectiveness of Opast tablet on subjective symptoms and neurologic claudication in patients with lumbar spinal stenosis.

Timeline

Start
2013-02
Primary completion
2013-10
Completion
2014-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Limaprost Small molecule 5 ug
Comparator Pregabalin Small molecule 75 mg

Indications